Sun Pharma Q2 Profit Drops 36% to Rs 1,989 Crore on Exceptional Charges
Sun Pharma reported a 36% year-on-year decline in Q2 profit to Rs 1,989 crore due to exceptional charges. However, revenue from operations increased by 12% to Rs 16,199 crore, driven by strong growth in its domestic formulations business and emerging markets compared to Rs 14,478 crore in the same quarter last year.
ET Markets·


